Studies on the roles of the membrane-associated matrix metalloproteinase regulator BECK in angiogenesis
Studies on the roles of the membrane-associated matrix metalloproteinase regulator BECK in angiogenesis
批准号:
13307008
负责人:
NODA Makoto
金额:
$18.14万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have discovered that forced expression of RECK in the HT1080 fibrosarcoma cells affects the processing of pro-MMP-2 in the culture supernatant and that mice lacking RECK expression die around embryonic day 10.5 with hemorrhage. We investigated the mechanisms of these phenomena and found that RECK inhibits both MT1-MMP and MMP-2 in vitro and that in mice lacking RECK expression, pro-MMP-2 processing is accelerated and collagen fibrils are dramatically reduced. Thus, the blood vessel disruption and mesenchymal disarray found in these mice may be due to the increased MMP-2 activation and this notion was further supported by the finding that MMP-2/RECK double mutant mice showed milder tissue damage and longer survival (0.5 day) (Oh et al. Cell 2001). In another line of studies which uses clinical samples, we found that RECK expression in several types of cancer (such as hepatocellular-carcinoma, pancreatic ductal carcinoma, non-samll cell Lung carcinoma), RECK expression in tumor tissues positively correlates with better prognosis (longer survival) and negatively correlates with activation of pro-MMP-2, invasiveness, and blood vessel density in tumors (Furumoto et al. Hepatology 2001; Masui et al. Clin. Cancer Res. 2003; Takanaka et al. Eur. J. Cancer 2004). We have also generated MMP-2/MT1-MMP double null mice, which are probably similar in effect to RECK-overexpressing mice, and found that they show peri-natal death with defects in blood vessel enlargement and muscle development (Oh et al. Oncogene 2004). The finding unexpectedly demonstrate that two MMPs with distinct molecular nature and subcellular localization are functionally redundant in vivo and that MMPs are indeed essential for extracellular matrix remodeling during mammalian embryonic development.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
J.Oh: "The Membrane-Anchored MMP-Inhibitor RECK is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis"Cell. 107. 789-800 (2001)
J.Oh:“膜锚定 MMP 抑制剂 RECK 是细胞外基质完整性和血管生成的关键调节剂”细胞。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Furumoto, S.Arii, A.Mori, H.Furuyama, M.J.Gorrin Rivas, T.Nakao, N.Isobe, T Murata, C.Takahashi, M.Noda, M.Imamura: "RECK gene expression in hepatocellular carcinoma: Correlation with invasion-related clinicopathological factors and its clinical signifi
K.Furumoto、S.Arii、A.Mori、H.Furuyama、M.J.Gorrin Rivas、T.Nakao、N.Isobe、T Murata、C.Takahashi、M.Noda、M.Imamura:“肝细胞癌中的 RECK 基因表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Ihara: "Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter"J. Cereb. Blood Fl. Met.. 21. 828-834 (2001)
M.Ihara:“慢性脑灌注不足会诱导白质小胶质细胞和血管内皮细胞中 MMP-2 的表达,但不会诱导 MMP-9 的表达”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
J.Oh, R.Takahashi, S.Kondo, A.Mizoguchi, E.Adachi, R.M.Sasahara, S.Nishimura, Y.Imamura, H.Kitayama 1, D.B.Alexander, C.Ide, T.P.Horan, T.Arakawa, H.Yoshida, S.Nishikawa, Y.Itoh, M.Seiki, S.Itohara, C.Takahashi, M.Noda: "The membrane-anchored MMP-inhibito
J.Oh、R.Takahashi、S.Kondo、A.Mizoguchi、E.Adachi、R.M.Sasahara、S.Nishimura、Y.Imamura、H.Kitayama 1、D.B.Alexander、C.Ide、T.P.Horan、T.Arakawa、
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
J.Oh: "Overlapping functions between two distinct matrix metalloproteinases, MMP-2 and MT1-MMP, in mouse"Oncogene. (印刷中).
J.Oh:“小鼠中两种不同基质金属蛋白酶(MMP-2 和 MT1-MMP)之间的重叠功能”Oncogene(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Elucidating the role of extracellular matrix remodeling on the fate and behavior of neuron
-
批准号:17024026
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$11.52万
-
财政年份:2005
-
负责人:NODA Makoto
-
依托单位:
Roles and Regulatory Mechanisms of Extracellular Matrix Remodeling in vivo
-
批准号:16GS0311
-
项目类别:Grant-in-Aid for Creative Scientific Research
-
资助金额:$385.8万
-
财政年份:2004
-
负责人:NODA Makoto
-
依托单位:
Screening for signal-responsive genes by an enhancer-trap vector and their application
-
批准号:11357002
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$20.16万
-
财政年份:1999
-
负责人:NODA Makoto
-
依托单位:
Search for gcncs rcgulating acuronal plasticity
-
批准号:07278105
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$132.67万
-
财政年份:1995
-
负责人:NODA Makoto
-
依托单位:
国内基金
海外基金
登录
查看更多内容
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: